or Try an Advanced Search...

    Pharmaceuticals Segment Stocks List

    Symbol Grade Name % Change
    NVO C Novo Nordisk A/S -0.47
    PRGO D Perrigo Company 3.18
    XPH D SPDR S&P Pharmaceuticals ETF 0.52
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone

    Related ETFs - A few ETFs which own one or more of the above listed Pharmaceuticals Segment stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 23.21
    PPH C Market Vectors Pharmaceutical ETF 10.43
    IGTR C Innovator Gradient Tactical Rotation Strategy ETF 8.56
    PJIO D PGIM Jennison International Opportunities ETF 7.68
    AADR A WCM BNY Mellon Focused Growth ADR ETF 6.52
    View all Pharmaceuticals Segment ETFs...
    Compare ETFs
    Compare EDEN to PPH Compare PPH to AADR Compare PPH to PJIO

        Pharmaceuticals Segment Stocks Recent News

        Date Stock Title
        May 8 NVO Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
        May 8 PRGO Perrigo First Quarter 2024 Earnings: EPS: US$0.03 (vs US$0.008 loss in 1Q 2023)
        May 7 PRGO Perrigo Company plc (PRGO) Q1 2024 Earnings Call Transcript
        May 7 PRGO Perrigo Company plc 2024 Q1 - Results - Earnings Call Presentation
        May 7 NVO 13 Best Stocks That Will Always Grow
        May 7 PRGO Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates
        May 7 PRGO Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
        May 7 PRGO Perrigo Co PLC (PRGO) Q1 2024 Earnings: Adjusted EPS Exceeds Expectations Despite Sales Dip
        May 7 PRGO Perrigo Non-GAAP EPS of $0.29, revenue of $1.08B
        May 7 PRGO Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations
        May 7 PRGO Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business
        May 6 NVO Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
        May 6 PRGO Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
        May 6 PRGO Perrigo Q1 2024 Earnings Preview
        May 6 PRGO Insights Into Perrigo (PRGO) Q1: Wall Street Projections for Key Metrics
        May 6 NVO Investors Pile Into Amgen in Search of Next Obesity Drug Payout
        May 6 NVO Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
        May 6 NVO 'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem
        May 4 NVO Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
        May 4 PRGO Perrigo (NYSE:PRGO) Is Due To Pay A Dividend Of $0.276
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone
        Pharmaceuticals Segment

        Pharmaceuticals segment is a sector of the healthcare industry that focuses on the research, development, production, and marketing of drugs and other pharmaceutical products. This segment includes companies that manufacture and distribute prescription and over-the-counter drugs, as well as those that provide related services such as contract manufacturing and clinical research.

        Browse All Tags